News

China Medical Technologies has posted unaudited preliminary financial results for the fourth fiscal quarter, 2008 and the full year of the fiscal 2008.   The company reports an

SOCMA has joined an international consortium, which works to enhance security and assure the quality and authenticity of products moving through the drug supply chain.   SOCMA is

Innocoll has declared positive provisional findings from its three phase-II clinical trials, to investigate collarx gentamicin topical for the treatment and prevention of infection in diabetic foot ulcers.

FDA has removed the clinical hold from Aastrom’ US phase-II Impact-Dcm clinical trial. Patient enrollment would resume at all five initiated clinical sites. The Impact-Dcm trial is evaluating

Vical is proceeding with the development of the RapidResponse platform under the third year of grant funding, awarded by the National Institute of Allergy and Infectious Diseases (NIAID).

Cephalon has provided results from a pivotal clinical trial of lestaurtinib (CEP-701), in patients with relapsed acute myelogenous leukemia (AML). Lestaurtinib is a potent inhibitor of several tyrosine

Oculus Innovative (Oculus) has reported preliminary results from its US 40-patient feasibility study, for the treatment of acne with Microcyn hydrogel formulation Cheryl Bongiovanni, Director, Lakes Aesthetics Center,

The Mayo Clinic has reported data on a prostate cancer study with ipilimumab, a fully human antibody that binds to CTLA-4 (cytotoxic T lymphocyte-associated antigen 4), a molecule

BioLine has announced the initiation of phase I/II clinical trial aimed at assessing the safety and efficacy of BL-5010, a novel formulation for the non surgical removal of